OGI

Organigram Global Inc. Common Shares (OGI)

Stock · NASDAQ · Health Care

$0.9278as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

OGI: Cannabis sector shows signs of profitability turnaround. A recent analysis suggests the cannabis sector is approaching a profitability turnaround despite weak price action. This context is relevant to Organigram Global, which trades near its 52-week low. The company's low P/E ratio of 2.5 may reflect this broader industry shift rather than just individual performance.

Active signals

Resistance level
$1.06
Industry
Biotechnology: Pharmaceutical Preparations

What OGI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike42-7.3%31%
Bollinger Band Breakout27-9.4%22%
Bollinger Band Breakdown190.0%47%
200-Day Moving Average TouchActive now10-6.4%30%
Any 20-session window (baseline)-2.8%43%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About OGI

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzle…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
1,139

Fundamentals

1-day range
$0.8952$0.9423
Market cap
$139.37M
P/E (trailing)
2.08
P/E (forward)
38.82
EPS (trailing)
$0.63
Dividend yield
—
Beta
1.69
Avg. volume
860.1K
52-week range
$1.2$3.09
Next earnings: December 15, 2026 · EPS estimate $0.01After Closeconfirmed

Organigram Global Inc. Common Shares Competitors

Chosen by industry and closest market cap.

  • OGI
    Organigram Global Inc. Common Shares
    $0.927
    ▼ 0.54%
    Market cap $139.37MP/E 2.08
    $1.2$3.09
  • UNCY
    Unicycive Therapeutics Inc. Common Stock
    $3.36
    ▼ 6.41%
    Market cap $138.33MP/E —
    $3.56$8.74
  • CNTB
    Connect Biopharma Holdings Limited Ordinary Shares
    $0.906
    ▲ 0.00%
    Market cap $137.89MP/E —
    $0.8501$3.82
  • KZIA
    Kazia Therapeutics Limited American Depositary Shares
    $7.25
    ▼ 2.03%
    Market cap $140.89MP/E —
    $4.86$17.4
  • NGEN
    NervGen Pharma Corp. Common stock
    $1.59
    ▼ 1.85%
    Market cap $141.37MP/E —
    $3.2$8.49
  • VTVT
    vTv Therapeutics Inc. Class A Common Stock
    $26.54
    ▼ 3.81%
    Market cap $136.33MP/E 55.59
    $19.5$44
  • CNTN
    Canton Strategic Holdings Inc. Common Stock
    $1.7
    ▼ 9.36%
    Market cap $143.45MP/E —
    $1.75$6.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
8.15M
Total value held
$10.99M
Institutional holders
75
Top holders this quarter
  • Unknown2.17M
  • Unknown1.64M
  • Unknown947.4K
  • Unknown571.4K
  • Unknown364.2K
  • Unknown346.8K
  • Unknown263.0K
  • Unknown238.1K
  • Unknown202.8K
  • Unknown173.9K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.